|
||
|
Chemical structures for Alendronbate, Ibandronate, Risedronate and Zoledronate. |
|
||||||||
| Part of: Ivanova S, Petkova V (2022) Specificity of clinical trials of some osteoporosis medicines. Pharmacia 69(1): 99-106. https://doi.org/10.3897/pharmacia.69.e79258 |